医薬品・バイオテクノロジー業界の販売契約 (2020～2025年)

本レポートでは、2020年から2025年までの医薬品・バイオテクノロジー業界の販売契約の詳細を提供しています。当事者間で発表された販売契約の支払い条件へのアクセスを提供し、支払い条件やその他の取引条件について有益な洞察を提供します。

主な利点

本レポートは、読者に以下の主な利点を提供します：

• 2020年以降の契約動向への理解
• 販売契約の閲覧
• ベンチマーク分析：取引の市場価値の把握
• 財務条件
• 契約ディレクトリ：企業別 (A～Z)、治療分野別、技術タイプ別
• 主要契約：金額別
• 最も活発な契約締結企業の特定
• 各取引の資産および契約条件の特定
• 契約文書へのアクセス：契約構造に関する洞察
• デューデリジェンス：提携企業に対する自社の契約条件の適合性の評価
• 数百時間の調査時間を節約可能

調査範囲

• バイオ製薬業界における販売契約の動向
• 販売契約構造の概要
• 製薬およびバイオテクノロジー分野における販売契約記録のディレクトリ
• 契約金額が大きい主要な販売契約
• 最も活発に販売契約を行っている企業
• 主要な販売提携リソース

利用可能な契約のリスト：

• 企業 (A～Z)
• 契約総額
• 治療分野
• 技術タイプ

目次

エグゼクティブサマリー

第1章 イントロダクション

第2章 販売契約の動向

• 販売契約の定義
• 2020年以降の販売契約の動向
  • 2020～2025年における販売契約：年別
  • 2020～2025年における販売契約：開発段階別
  • 2020～2025年における販売契約：業界別
  • 2020～2025年における販売契約：治療領域別
  • 2020～2025年における販売契約：技術タイプ別
  • 2020～2025年における販売契約：最も活発な企業別
  • 純粋な販売契約の属性
  • 複合型契約における販売契約の属性
• パートナーを調整し、販売契約を機能させるための取り組み

第3章 販売契約の構造：概要

• 販売契約の構造
• より広範な販売契約の一環としての販売権

第4章 主要な販売契約

• トップ販売契約：金額別

第5章 最も活発な販売契約企業：トップ25社

• 最も活発な販売契約企業：トップ25社

第6章 契約ディレクトリを含む販売契約

• 2020年から2025年までの契約を含む販売契約
• 契約ディレクトリ
• 契約ディレクトリ- 企業別販売契約 (A-Z)
• 契約ディレクトリ- 治療領域別の販売契約
• 契約ディレクトリ- 技術タイプ別の販売契約
• Biopharma Researchについて
• 現在の提携
• 現在の契約
• Current Partneringからの最近のレポートタイトル

Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2020 to 2025.

The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of distribution deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the distribution deal.

The deal directory includes a comprehensive listing of all distribution deals announced since 2020. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.

Key benefits

Distribution Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse distribution deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Distribution Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the distribution trends and structure of deals entered into by leading biopharma companies worldwide.

Distribution Deals in Pharmaceuticals and Biotechnology includes:

• Trends in distribution dealmaking in the biopharma industry
• Overview of distribution deal structure
• Directory of distribution deal records covering pharmaceutical and biotechnology
• The leading distribution deals by value
• Most active distribution dealmakers
• The leading distribution partnering resources

In Distribution Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Distribution Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for distribution deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deals
• 2.3. Trends in distribution deals since 2020
  • 2.3.1. Distribution dealmaking by year, 2020-2025
  • 2.3.2. Distribution dealmaking by phase of development, 2020-2025
  • 2.3.3. Distribution dealmaking by industry sector, 2020-2025
  • 2.3.4. Distribution dealmaking by therapy area, 2020-2025
  • 2.3.5. Distribution dealmaking by technology type, 2020-2025
  • 2.3.6. Distribution dealmaking by most active company, 2020-2025
  • 2.3.7. Attributes of pure distribution deals
  • 2.3.8. Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3. Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers

Chapter 6 - Distribution deals including contracts directory

• 6.1. Introduction
• 6.2. Distribution deals with contracts 2020-2025
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements, 2020-2025
• Figure 3: Distribution deals signed at each phase of development, 2020-2025
• Figure 4: Distribution deals by industry sector, 2020-2025
• Figure 5: Distribution deals by therapy area, 2020-2025
• Figure 6: Distribution deals by technology type, 2020-2025
• Figure 7: Top 25 most active distribution dealmakers, 2020-2025
• Figure 8: Issues in implementing distribution agreements
• Figure 9: Distribution agreements - what should a contract include?
• Figure 10: Components of the distribution deal structure
• Figure 11: Top distribution deals by value 2020-2025
• Figure 12: Most active distribution dealmakers 2020-2025